Sky Century Investment (SKYI) EBITDA Margin Growth (1y) (2025 - 2026)

Sky Century Investment (SKYI) EBITDA Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 304.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -157.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,330.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -650.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 8,630.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1,962.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 111.00
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 3,097.00

Historic Data

Download Data
DateValue
May 31, 2026 3,097.00
Feb 28, 2026 20,275.00
Aug 31, 2025 -9,761.00
Feb 28, 2025 6,737.00